CRISPR Therapeutics AG (CRSP)
60.14
-1.60
(-2.59%)
USD |
NASDAQ |
Feb 27, 16:00
59.70
-0.44
(-0.73%)
After-Hours: 20:00
CRISPR Therapeutics Free Cash Flow : -345.93M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.194B |
| Beam Therapeutics, Inc. | -360.05M |
| Novartis AG | 15.32B |
| EvoNext Holdings SA | -1.228M |
| Kuros Biosciences Ltd. | -0.9723M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -92.55M |
| Cash from Investing (Quarterly) | 37.20M |
| Cash from Financing (Quarterly) | 116.41M |
| Free Cash Flow Per Share (Quarterly) | -0.9769 |
| Free Cash Flow to Equity (Quarterly) | -88.79M |
| Free Cash Flow to Firm (Quarterly) | -93.07M |
| Free Cash Flow Yield | -6.40% |